You are here

Accelerate MedTech Summit

March 18, 2020
Newport Beach, CA
Conference

COVID-19 Update

After careful consideration, we have made the difficult decision to postpone the 2020 AdvaMed CEO Summit and Accelerate MedTech Summit due to the coronavirus outbreak. This action reflects an abundance of concern for everyone’s personal health at this time. The state of California has declared a public health emergency following numerous confirmed cases of the coronavirus (COVID-19); and, the Orange County Board of Supervisors has declared a local emergency after a confirmed case of COVID-19 in the area. We have begun to see an increase in the number of confirmed COVID-19 cases in the U.S., cancellations of many major conferences, and significant travel restrictions for many businesses, including medtech companies.

We are currently exploring the potential to reschedule the Summit’s events for a later date. We are working through a series of options and will keep you informed as these plans develop. 

Meanwhile, the number one priority for AdvaMed’s Events and Education team will remain the health and safety of our event participants. For more information on COVID-19, please visit the CDC web page here.

If you have any questions regarding the Summit or other AdvaMed events, please contact our team at advamedevents@advamed.org.

Download the full agenda

TUESDAY, MARCH 17, 2020

6:30 pm – 7:30 pm (Pelican Hill Resort – Pacific Terrace)

CEO Summit Closing Reception

7:30 pm – 9:30 pm (Pelican Hill Resort – Mar Vista Event Lawn)

CEO Summit Closing Networking Dinner

*Register early, seating is limited

 
WEDNESDAY, MARCH 18, 2020
(DRESS CODE: CASUAL)                                          

6:45 am – 9:15 am (Newport Beach Marriott Hotel – Atrium)

Breakfast

 
7:00 am – 8:45 am (Newport Beach Marriott Hotel – Laguna & Sunset)

AdvaMed Accel Board Meeting

  • 7:00 am – 7:45 am: Executive Session
  • 7:45 am – 8:45 am: Policy Roundtable

9:00 am – 9:15 am (Newport Beach Marriott Hotel – Baycliff)

2020 MedTech Industry Outlook – A Near "Perfect Storm"?

In 2019, the value of device exits reached a new high, driven by private M&A, IPO values, and public market performance. Combined with policy changes that create an environment more conducive to innovation, we are observing increased investment in medtech. One of the industry’s leading equity analysts, will share his views on what 2020 will hold, followed by a discussion with top industry executives.

  • Moderator: David Lewis, Managing Director, Medical Device Analyst, Morgan Stanley

 
9:15 am – 10:15 am (Newport Beach Marriott Hotel – Baycliff)

Corporate CEO Spotlight Panel

  • Moderator: David Lewis, Managing Director, Medical Device Analyst, Morgan Stanley
  • Lisa D. Earnhardt, Executive Vice President, Medical Devices, Abbott
  • Vince Forlenza, Chairman of the Board, BD
  • Michael F. Mahoney, Chairman and Chief Executive Officer, Boston Scientific (Invited)
  • Erica J. Rogers, President & CEO, Silk Road Medical (Invited)

 
10:15 am – 11:15 am (Newport Beach Marriott Hotel – Baycliff)     

Unleashing Innovation – How Insurers are Working to Improve Patient Access

Insurers are seeking to remove the barriers that limit innovation and improve patient access to new and better treatments, which are essential for a healthcare system where providers and health plans compete to deliver better care at lower costs. One patient’s story will illustrate the tremendous impact of innovative medtech, providing a backdrop for examining how insurers are driving the uptake of new technologies.

11:15 am – 11:30 am (Newport Beach Marriott Hotel – Atrium)

Networking Break

11:30 am – 12:30 pm (Newport Beach Marriott Hotel – Baycliff)

Provider Adoption of Innovative Medical Technologies

While provider adoption of innovation can be challenging to achieve, there are several hospital systems vying to be first to offer novel solutions to their patient populations – even before such technologies have secured stable reimbursement and achieved other efficiencies that come for late adopters. Hear from the forward-thinkers in healthcare delivery that are blazing the trail and improving patient outcomes by doing so.

  • Moderator: Venk Varadan, Co-Founder and CEO, Nanowear
  • Jessica Chao, Director, Clinical Innovation Center, UCSF Innovation Ventures
  • Dr. Karl Poterack, Medical Director, Applied Clinical Informatics, Mayo Clinic
  • Dr. Sharief Taraman, Chief of Neurology, Children’s Hospital of Orange County

12:30 pm – 1:30 pm (Newport Beach Marriott Hotel – Baycliff)

Networking Lunch

Keynote: The Patient Impact of FDA’s Breakthrough Pathway: The Barostim Therapy™ Story  

  • Moderator: David Cassak, Co-Editor-in-Chief and Managing Partner, MedTech Strategist (Invited)
  • William Maisel, MD, MPH, Chief Medical Officer and Director, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, FDA
  • Nadim Yared, President and CEO, CVRx

1:45 pm – 2:45 pm (Newport Beach Marriott Hotel – Baycliff)         

MedTech Investing Today – The Next Challenge in the Innovation Capital Continuum

Over the past two years, several new medtech funds have closed, driven in part by a series of healthy exits. While available capital has increased overall, some investors are feeling the effects of the Series A drought of years past. Join this discussion that will explore where medtech investments are heading – and how the ecosystem can work together to fill existing innovation gaps.

  • Moderator: Michael White, Head of Sales Origination, Life Science and Healthcare, Silicon Valley Bank
  • Greg Madden, Partner, SV Health Investors
  • Todd Pope, Operating Partner, Revival Healthcare Capital
  • Valeska Schroeder, Managing Director, KCK Group
  • Cynthia Yee, Principal, Vensana Capital

 
2:45 pm – 3:00 pm (Newport Beach Marriott Hotel – Baycliff)

Networking Break

 
3:00 pm – 3:45 pm (Newport Beach Marriott Hotel – Baycliff)

Developing an Exit Strategy – The Importance of Demonstrating Value

In medtech, we’re focused on delivering “value.” Value for the patient, value for the healthcare system, etc. For many small companies, the journey ultimately ends in exit value. In this session, learn how Clinical Innovations strategically worked to achieve the organization’s full potential, resulting in a successful exit – much earlier than planned.

  • Moderator: Delphine Zurkiya, Partner, McKinsey & Company
  • Ken Reali, President and CEO, Clinical Innovations

3:45 pm – 4:00 pm (Newport Beach Marriott Hotel – Atrium)

Networking Break

4:00 pm – 4:30 pm (Newport Beach Marriott Hotel – Baycliff)

CEO Fireside Chat

  • Moderator: David Uffer, Senior Partner, VP of MedTech, Alira Health
  • Martha Shadan, President and CEO, Miach Orthopaedics and Chairwoman, AdvaMed Accel
  • Renee Ryan, CEO, Cala Health

4:30 pm – 5:30 pm (Newport Beach Marriott Hotel – Baycliff)

Partnering Roundtables – Worst Practices in MedTech Partnering (Real-World Mistakes to Avoid) 

Facilitated discussions in small groups about the worst/best practices in fundraising (and other topics). Attendees will have the opportunity to rotate between tables with investors and other industry stakeholders sharing the mistakes they WILL NOT make again and how to build effective relationships with funding and strategic partners.

5:30 pm – 7:00 pm (Newport Beach Marriott Hotel – Atrium)

Networking Reception

  • Jessica Chao, Director, Clinical Innovation Center, UCSF Innovation Ventures
  • Lisa D. Earnhardt, Executive Vice President, Medical Devices, Abbott
  • Frank Fischer, Chairman, NeuroPace
  • Vince Forlenza, Chairman of the Board, BD
  • Jo Carol Hiatt, MD, MBA, FACS, Chair, National Product Council, Kaiser Permanente
  • Stephen Levin, Co-Editor-in-Chief and Managing Partner, MedTech Strategist and Market Pathways
  • David Lewis, Managing Director, Medical Device Analyst, Morgan Stanley
  • Greg Madden, Partner, SV Health Investors
  • Michael F. Mahoney, Chairman and Chief Executive Officer, Boston Scientific
  • William Maisel, MD, MPH, Chief Medical Officer and Director, Office of Product Evaluation and Quality, Center for Devices and Radiological Health, FDA
  • Dr. Karl Poterack, Medical Director, Applied Clinical Informatics at Mayo Clinic; Anesthesiologist/Clinical Informaticist
  • Todd Pope, Chairman of the Board of Directors, Lumagenics
  • Ken Reali, President and CEO, Clinical Innovations
  • Kathleen Rivas, NeuroPace Patient Ambassador
  • Renee Ryan, CEO, Cala Health
  • Valeska Schroeder, Managing Director, KCK Group
  • Martha Shadan, President and CEO, Miach Orthopaedics and Chairwoman, AdvaMed Accel
  • Dr. Sharief Taraman, Chief of Neurology, Children’s Hospital of Orange County
  • David Uffer, Senior Partner, VP of MedTech, Alira Health
  • Venk Varadan, Co-Founder and CEO, Nanowear
  • Michael White, Head of Sales Origination, Life Science and Healthcare, Silicon Valley Bank
  • Nadim Yared, President and CEO, CVRx
  • Cynthia Yee, Principal, Vensana Capital
  • Delphine Zurkiya, Partner, McKinsey & Company

The Accelerate MedTech Summit will take place on March 18 at the Newport Beach Marriot Hotel.

Address:
Newport Beach Marriott Hotel
900 Newport Center Drive
Newport Beach, CA 92660

The AdvaMed group rate of $219/night is no longer available, but please contact group housing coordinator Alisha Gill at 949-729-6933 or alisha.gill@marriott.com for availability and reservations.

Hotel block dates:  Sunday, March 15 through Wednesday, March 18

Registration Fees

AdvaMed Member Registration: $600.00

Non-Member Registration: $750.00